Glyco Biopharma

Hyderabad, India Founded: 2018 • Age: 8 yrs
Provides comprehensive solutions in feed supplements and antibiotics for poultry, aquaculture, and veterinary sectors.
Annual revenue $430,578 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Glyco Biopharma

Glyco Biopharma is a company based in Hyderabad (India) founded in 2018. It operates as a B2B. Glyco Biopharma operates in a competitive market with competitors including Zoetis, Ceva, PetMedix, QBiotics and Hester Biosciences, among others.

  • Headquarter Hyderabad, India
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Glyco Bio Pharma Private Limited
  • Date of Incorporation 28 Jun, 2017
  • Jurisdiction Hyderabad, Telangana, India
Operational Areas
Healthcare → Veterinary & Animal Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $430.58 K (USD)
    41.84
    as on Mar 31, 2022
  • Net Profit
    $8.29 K (USD)
    159.16
    as on Mar 31, 2022
  • EBITDA
    $34.81 K (USD)
    32.74
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Glyco Biopharma

Premium access

Detailed funding history for Glyco Biopharma

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Glyco Biopharma

Investments
Premium access

Investment portfolio details for Glyco Biopharma

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Glyco Biopharma

Premium access

Detailed financials for Glyco Biopharma

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Glyco Biopharma Comparisons

Glyco Biopharma Primary company
Description
Provides comprehensive solutions in feed supplements and ant...
Location
Hyderabad, India
Founded Year
2018
Annual Revenue
$430.58 K (USD)
Net Profit
$8.29 K (USD)
EBITDA
$34.81 K (USD)
Employees
Not available
Premium access

Peer comparison for Glyco Biopharma

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Glyco Biopharma

Glyco Biopharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zoetis, Ceva, PetMedix, QBiotics and Hester Biosciences, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
Locked Locked Locked
Animal health therapeutics are developed and supplied globally by Ceva.
Locked Locked Locked
Developer of monoclonal antibody therapeutics for pets
Locked Locked Locked
Small molecules from plant extracts are developed for medical applications.
Locked Locked Locked
Manufacturer of animal vaccines and healthcare products
Locked Locked Locked
Biopharmaceuticals for animals are manufactured and supplied through partnerships.
Premium access

Detailed competitors of Glyco Biopharma

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Glyco Biopharma

Premium access

Complete news archive for Glyco Biopharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Glyco Biopharma

Glyco Biopharma was founded in 2018.

Glyco Biopharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Annual revenue of Glyco Biopharma is $430.58K as on Mar 31, 2022.

Glyco Biopharma provides comprehensive solutions in feed supplements and antibiotics for poultry, aquaculture, and veterinary sectors through providing healthcare solutions, producing pharmaceutical products, veterinary medicine, and feed supplements and antibiotics. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.

Glyco Biopharma's top competitors include Zoetis, Ceva and QBiotics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available